An isolated hypogonadotropic hypogonadism male with a novel de novo FGFR1 mutation fathered a normal son evidenced by prenatal genetic diagnosis
- 29 September 2020
- journal article
- research article
- Published by Wiley in Andrologia
- Vol. 52 (11) , e13821
Abstract
Isolated hypogonadotropic hypogonadism (IHH) is a rare but treatable form of male infertility caused by congenital defect in gonadotropin‐releasing hormone (GnRH) secretion or action. We report a Chinese IHH male with a novel FGFR1 mutation who successfully fathered a normal son. Targeted next‐generation sequencing, bioinformatics analysis and Sanger sequencing were performed by using the DNA extracted from the pedigree. The patient was treated with gonadotropin and was able to impregnant his wife during the treatment. Amniocentesis was performed at the 18 weeks of gestation. A novel de novo pathogenic missense variant (c.980A>G, p.Asn327Ser) in exon 8 in FGFR1 gene (NM_001174067.1) was identified in the patient but not in his normal parents. This variant was also absent in the DNA obtained from the amniocentesis sample. His son has normal growth and development at the age of 2 years. This is the first case of prenatal genetic diagnosis based on the genetic testing of the IHH father by combining targeted next‐generation and Sanger sequencing in IHH family. We extended the mutation spectrum of FGFR1 in IHH patients. Prenatal genetic diagnosis based on the results of genetic testing of the IHH patients may be helpful in the genetic counselling for the IHH families.Keywords
Funding Information
- National Natural Science Foundation of China (81601270, 81700413)
This publication has 11 references indexed in Scilit:
- Mutation profiles and clinical characteristics of Chinese males with isolated hypogonadotropic hypogonadismFertility and Sterility, 2018
- Evaluation and Management of Testosterone Deficiency: AUA GuidelineJournal of Urology, 2018
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Prioritizing Genetic Testing in Patients With Kallmann Syndrome Using Clinical PhenotypesThe Journal of Clinical Endocrinology & Metabolism, 2013
- Expanding the Phenotype and Genotype of Female GnRH DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 2011
- Screening of autosomal gene deletions in patients with hypogonadotropic hypogonadism using multiplex ligation‐dependent probe amplification: detection of a hemizygosis for the fibroblast growth factor receptor 1Clinical Endocrinology, 2010
- Reversal of Idiopathic Hypogonadotropic HypogonadismNew England Journal of Medicine, 2007
- Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadismProceedings of the National Academy of Sciences, 2006
- Gonadotrophin therapy in Kallmann syndrome caused by heterozygous mutations of the gene for fibroblast growth factor receptor 1: report of three families:Case reportHuman Reproduction, 2005
- Reversible Kallmann Syndrome, Delayed Puberty, and Isolated Anosmia Occurring in a Single Family with a Mutation in the Fibroblast Growth Factor Receptor 1 GeneThe Journal of Clinical Endocrinology & Metabolism, 2005